Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia

NCT02611973 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

2250

Enrollment

OTHER

Sponsor class

Conditions

MPN
Essential Thrombocythemia

Interventions

OTHER: Aspirin therapy interruption
OTHER: Usual treatment by aspirin 100 mg/d in the active comparator arm
OTHER: No interruption of aspirin in the Observational arm
DRUG: Hydroxyurea treatment (HU)

Sponsor

Assistance Publique - Hôpitaux de Paris